Inhalation Drug Delivery: The Impact of Particle Size Reduction
Pharmaceutical Technology, September 2, 2019
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Pharmaceutical Technology, September 2, 2019
European Industrial Pharmacy, June 2013
By Jorge Pastilha, Director of Logistics & Control and Filipe Gaspar, PhD, Process Engineer
Drug Development & Delivery, June 2020
Chemistry Today, July/August 2010
Our service for HPAPIs ranges from Drug Substance to Particle Engineering.
Hovione’s assets represent value for life cycle management strategies, drugs repurposed route of administrations and paragraph IV opportunities in technically difficult generics.
Hovione has extensive manufacturing capacity in Particle Engineering providing the right scale and flexibility for all our customers.